Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AM001 Cream in Plaque Psoriasis
NCT01938599Phase 2Completed
- Sponsor
- AmDerma Pharmaceuticals
- Start
- Aug 2013
- Primary completion
- May 2014
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in plaque psoriasis comparing AM001 Cream with Vehicle (2 arms). Primary endpoint: Investigator's Global Assessment at 12 weeks. Started Aug 2013; status: completed.
02
Drugs
potassium dobesilate
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01938599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01938599.